
Sign up to save your podcasts
Or


How does a vaccine get developed, studied, approved, distributed, and administered, and then just … disappear? On Episode 34 of The Politics of Everything, hosts Laura Marsh and Alex Pareene explore what happened to LYMErix, a vaccine for Lyme disease that has been called the only safe and effective vaccine ever to have been voluntarily withdrawn from the market in the United States. What does the story of LYMErix tell us about vaccine hesitancy, liability, and how pharmaceutical companies decide what to sell? And can we expect another Lyme vaccine anytime soon? Guests include Rebecca Onion, who wrote about LYMErix for Slate, and Andrew Zaleski, who wrote about new prophylactic treatments for Lyme for Outside magazine.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The New Republic & Talkhouse4.3
227227 ratings
How does a vaccine get developed, studied, approved, distributed, and administered, and then just … disappear? On Episode 34 of The Politics of Everything, hosts Laura Marsh and Alex Pareene explore what happened to LYMErix, a vaccine for Lyme disease that has been called the only safe and effective vaccine ever to have been voluntarily withdrawn from the market in the United States. What does the story of LYMErix tell us about vaccine hesitancy, liability, and how pharmaceutical companies decide what to sell? And can we expect another Lyme vaccine anytime soon? Guests include Rebecca Onion, who wrote about LYMErix for Slate, and Andrew Zaleski, who wrote about new prophylactic treatments for Lyme for Outside magazine.
Learn more about your ad choices. Visit megaphone.fm/adchoices

43,998 Listeners

142 Listeners

245 Listeners

389 Listeners

87,527 Listeners

307 Listeners

12,577 Listeners

5 Listeners

373 Listeners

1,518 Listeners

367 Listeners

158 Listeners

144 Listeners

42 Listeners

9,361 Listeners

779 Listeners

52 Listeners

14 Listeners

47 Listeners

64 Listeners

19 Listeners

35 Listeners

3 Listeners